ARK Survival Ascended UE5.5 update has been delayed (hopefully, for the last time). Sometime ago, developers took to their blog to make a last-minute announcement, stating that they were going to hold ...

The Lost King is one of the main bosses of Arta Prime. He was initially revealed in the trailer and is someone everyone anticipated. The fight takes place in his palace, a dungeon with multiple stages ...

Studio Wildcard has revealed that ARK Survival Ascended is “in active development” for Nintendo Switch 2. That has been made ...

This week was always destined to be one of the most important in Ark's history. Lost Colony, the new DLC for Ark Survival Ascended, is the first totally original, full-size expansion that Ark fans ...

Studio Wildcard has revealed that it's planning on releasing Ark 2, the full-fledged sequel to the original Ark: Survival Evolved, in 2028. Studio Wildcard co-founder Jeremy Stieglitz gave a fairly ...

Given that Ark 2 is coming and that Ark: Survival Ascended is steadily building the bridge to the sequel, Lost Colony feels like a very apocalyptic, dark setting that, in many ways, feels like the ...

What are the best Ark mods in 2026? The dino-survival multiplayer game has been immensely popular ever since it was released seven years ago, with a whole host of content added post-launch. If you've ...

For centuries, people have tried in vain to locate and recover the Bible's most sacred objects. Among the most sought-after of these religious antiquities is the famed Ark of the Covenant. This ...

The total number of shares of a security that have been sold short and not yet repurchased. Change from Last Percentage change in short interest from the previous report to the most recent report.

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Andy Smith is a Certified Financial Planner (CFP®), licensed realtor and educator with over ...

Structure-based drug design is the design and optimization of a chemical structure with the goal of identifying a compound suitable for clinical testing — a drug candidate. It is based on knowledge of ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...